{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:05:15Z","timestamp":1791299115862,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jbspin.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T10:46:17Z","timestamp":1334832377000},"page":"304-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis"],"prefix":"10.1016","volume":"79","author":[{"given":"Karine","family":"Briot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Audran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Blain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Breuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Chapuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Fardellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Feron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Gauvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Guggenbuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Kolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lespessailles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Letombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Orcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Seret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tr\u00e9molli\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2012.02.014_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project","volume":"12","author":"AGREE Collaboration","year":"2003","journal-title":"Qual Saf Health Care."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0370","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0020","series-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO Technical Report Series no. 843","author":"World Health Organization (WHO)","year":"1994"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0025","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1210\/jc.2004-0124","article-title":"Official position of the International Society for Clinical Densitometry","volume":"89","author":"Lewiecki","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s001980050281","article-title":"An update on the diagnosis and assessment of osteoporosis with densitometry","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"A reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0040","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00198-010-1336-9","article-title":"International variation in proximal femur bone mineral density","volume":"22","author":"Paggiosi","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures","volume":"5","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0050","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0060","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jbmr.35","article-title":"Manitoba Bone Density Program. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures","volume":"25","author":"Giangregorio","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jocd.2007.12.008","article-title":"Vertebral fracture assessment: the 2007 ISCD official positions","volume":"11","author":"Schousboe","year":"2008","journal-title":"J Clin Densitom."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0070","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study","volume":"34","author":"Schuit Sc","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0080","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/JBMR.050609","article-title":"Identification of osteopenic women at high risk of fracture: the OFELY study","volume":"20","author":"Sornay-Rendu","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(96)01440-7","article-title":"Fall-related factors and risk of hip fracture: the EPIDOS prospective study","volume":"348","author":"Dargent-Molina","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u00ae and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0095","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinternmed.2009.404","article-title":"A comparison of prediction models for fractures in older women: is more better?","volume":"169","author":"Ensrud","year":"2009","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1359\/jbmr.090511","article-title":"FRAX and risk of vertebral fractures: the Fracture Intervention Trial","volume":"24","author":"Donaldson","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0105","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/jbmr.106","article-title":"The FRAX tool in French women: how well does it describe the real incidence of fracture in the OFELY cohort?","volume":"25","author":"Sornay-Rendu","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0110","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jbmr.12","article-title":"Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women. Sensitivity of the WHO FRAX tool","volume":"25","author":"Tr\u00e9mollieres","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0115","article-title":"FRAX\u00ae probabilities and risk of major osteoporotic fracture in France","author":"Couris","year":"2011","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1503\/cmaj.111158","article-title":"Closing the gap in postfracture care at the population level: a randomized controlled trial","volume":"184","author":"Leslie","year":"2012","journal-title":"CMAJ."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0125","first-page":"CD001255","article-title":"Hip protectors for preventing hip fractures in older people","volume":"10","author":"Gillespie","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.39440.525752.BE","article-title":"Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial","volume":"336","author":"Bolland","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0140","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.maturitas.2009.03.006","article-title":"Use of calcium supplementation and the risk of coronary heart disease in 52\u201362-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study","volume":"63","author":"Pentti","year":"2009","journal-title":"Maturitas."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0150","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"BMJ."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.176","article-title":"Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up","volume":"26","author":"Lewis","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lpm.2011.04.001","article-title":"La vitamine D chez l\u2019adulte: recommandations du GRIO [In French]","volume":"40","author":"Benhamou","year":"2011","journal-title":"Press Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0165","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0170","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0180","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0190","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-011-1847-z","article-title":"Maintenance of antifracture efficacy over 10\u00a0years with strontium ranelate in postmenopausal osteoporosis","volume":"23","author":"Reginster","year":"2012","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0195","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0200","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","author":"Black","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0205","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0210","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00198-004-1709-z","article-title":"The accuracy of height loss during prospective monitoring for detection of incident vertebral fractures","volume":"16","author":"Siminoski","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00198-005-2017-y","article-title":"The accuracy of historical height loss for the detection of vertebral fractures in postmenopausal women","volume":"17","author":"Siminoski","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0225","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1503\/cmaj.090710","article-title":"Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women","volume":"6","author":"Briot","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0230","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"Schwartz","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0235","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0240","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1359\/JBMR.050501","article-title":"Sustained non-vertebral fragility fracture risk reduction after discontinuation of teriparatide treatment","volume":"20","author":"Prince","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0245","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","article-title":"Smallest detectable difference in individual bone mineral density measurements","volume":"14","author":"Ravaud","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0250","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0255","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3 years randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0260","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0265","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0270","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Rewiews"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0275","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0280","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effect of risedronate treatment on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0290","first-page":"CD004523","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0295","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2004.52506.x","article-title":"Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old","volume":"52","author":"Boonen","year":"2004","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0300","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0305","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0310","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1532-5415.2009.02673.x","article-title":"Efficacy and safety of a once-yearly intravenous zoledronic acid 5mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older","volume":"58","author":"Boonen","year":"2010","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0315","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0325","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00198-008-0825-6","article-title":"Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis","volume":"20","author":"Meunier","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0330","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0335","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","article-title":"Effects of long-term strontium ranelate treatment on the risk of non-vertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial","volume":"58","author":"Reginster","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.060101","article-title":"Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors","volume":"4","author":"Roux","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0345","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.060404","article-title":"Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in women eighty years of age and older","volume":"21","author":"Seeman","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0350","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbspin.2012.02.014_bib0355","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of non-vertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study groups","volume":"277","author":"Karpf","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0360","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"Mac Clung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2012.02.014_bib0365","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","article-title":"Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women","volume":"16","author":"Papapoulos","year":"2005","journal-title":"Osteoporos Int"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1200053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X1200053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:23:07Z","timestamp":1761150187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X1200053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1297319X1200053X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2012.02.014","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2012.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}